期刊文献+

Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles 被引量:25

Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles
下载PDF
导出
摘要 One of the most prominent characteristics of gastrointestinal stromal tumors(GISTs) is their unpredictable and variable behavior. GISTs are not classified as "benign" or "malignant" but are rather stratified by their associated clinical risk of malignancy as determined by tumor size, location, and number of mitoses identified during surgicalhistology. The difficulty in assessing the malignant potential and prognoses of GISTs as well as the increasing incidence of "incidental GISTs" presents challenges to gastroenterologists. Recently, endoscopic enucleation has been actively performed as both a diagnostic and therapeutic intervention for GISTs. Endoscopic enucleation has several advantages, including keeping the stomach intact after the removal of GISTs, a relatively short hospital stay, a conscious sedation procedure, relatively low cost, and fewer human resources required compared with surgery. However, a low complete resection rate and the risk of perforation could reduce the overall advantages of this procedure. Endoscopic full-thickness resection appears to achieve a very high R0 resection rate. However, this technique absolutely requires a very skilled operator. Moreover, there is a risk of peritoneal seeding due to large active perforation. Laparoscopy endoscopy collaborations have been applied for more stable and pathologically acceptable management. These collaborative procedures have produced excellent outcomes. Many procedures have been developed and attempted because they were technically possible. However, we should first consider the theoretical basis for each technique. Until the efficacy and safety of sole endoscopic access are proved, the laparoscopy endoscopy collaborative procedure appears to be an appropriate method for minimally destructive GIST surgery. One of the most prominent characteristics ofgastrointestinal stromal tumors (GISTs) is theirunpredictable and variable behavior. GISTs arenot classified as "benign" or "malignant" but arerather stratified by their associated clinical risk ofmalignancy as determined by tumor size, location,and number of mitoses identified during surgicalhistology. The difficulty in assessing the malignantpotential and prognoses of GISTs as well as theincreasing incidence of "incidental GISTs" presentschallenges to gastroenterologists. Recently, endoscopicenucleation has been actively performed as both adiagnostic and therapeutic intervention for GISTs.Endoscopic enucleation has several advantages,including keeping the stomach intact after the removalof GISTs, a relatively short hospital stay, a conscioussedation procedure, relatively low cost, and fewerhuman resources required compared with surgery.However, a low complete resection rate and the risk ofperforation could reduce the overall advantages of thisprocedure. Endoscopic full-thickness resection appearsto achieve a very high R0 resection rate. However, thistechnique absolutely requires a very skilled operator.Moreover, there is a risk of peritoneal seeding dueto large active perforation. Laparoscopy endoscopycollaborations have been applied for more stableand pathologically acceptable management. Thesecollaborative procedures have produced excellentoutcomes. Many procedures have been developed andattempted because they were technically possible.However, we should first consider the theoretical basisfor each technique. Until the efficacy and safety ofsole endoscopic access are proved, the laparoscopyendoscopy collaborative procedure appears to be anappropriate method for minimally destructive GISTsurgery.
作者 Hyung Hun Kim
出处 《World Journal of Gastrointestinal Endoscopy》 CAS 2015年第3期192-205,共14页 世界胃肠内镜杂志(英文版)(电子版)
基金 Supported by The Science Research Program through the National Research Foundation of Korea(NRF) the Ministry of Science,ICT and Future Planning,No.NRF-2013R1A1A1009682
关键词 GASTROINTESTINAL STROMAL TUMOR ENDOSCOPY LAPAROSCOPY EFFICACY Safety Gastrointestinal stromal tumor Endoscopy Laparoscopy Efficacy Safety
  • 相关文献

参考文献2

二级参考文献17

  • 1Ioannis S Papanikolaou,Konstantinos Triantafyllou,Anastasia Kourikou,Thomas Rsch.Endoscopic ultrasonography for gastric submucosal lesions[J].World Journal of Gastrointestinal Endoscopy,2011,3(5):86-94. 被引量:49
  • 2Kazuya Akahoshi,Masafumi Oya.Gastrointestinal stromal tumor of the stomach:How to manage?[J].World Journal of Gastrointestinal Endoscopy,2010,2(8):271-277. 被引量:16
  • 3Laura Graves Ponsaing,Mark Berner Hansen.Therapeutic procedures for submucosal tumors in the gastrointestinal tract[J].World Journal of Gastroenterology,2007,13(24):3316-3322. 被引量:29
  • 4Zhankun He,Chao Sun,Jiang Wang,Zhongqing Zheng,Qingxiang Yu,Tao Wang,Xin Chen,Wentian Liu,Bangmao Wang.Efficacy and safety of endoscopic submucosal dissection in treating gastric subepithelial tumors originating in the muscularis propria layer: a single-center study of 144 cases[J].Scandinavian Journal of Gastroenterology.2013(12)
  • 5Yasuhiro Miyazaki,Kiyokazu Nakajima,Yukinori Kurokawa,Tsuyoshi Takahashi,Shuji Takiguchi,Hiroshi Miyata,Makoto Yamasaki,Seiichi Hirota,Toshirou Nishida,Masaki Mori,Yuichiro Doki.Clinical significance of surgery for gastric submucosal tumours with size enlargement during watchful waiting period[J].European Journal of Cancer.2013(12)
  • 6Takahiko Nakajima,Tomonori Ushijima,Atsushi Kihara,Kenichiro Murata,Toshiro Sugiyama,Koichi Tsuneyama,Johji Imura,Junichi Fukushima,Hajime Horiuchi,N. Reddy,J. Watari.A Gastrointestinal Stromal Tumor of the Stomach Demonstrating a Stepwise Progression from Low- to High-Grade Malignancy[J].Case Reports in Gastrointestinal Medicine.2012
  • 7Joseph J. Bennett,Matthew S. Rubino.Gastrointestinal Stromal Tumors of the Stomach[J].Surgical Oncology Clinics of North America.2012(1)
  • 8Takuto Suzuki,Makoto Arai,Tomoaki Matsumura,Eiji Arai,Sachio Hata,Daisuke Maruoka,Takeshi Tanaka,Shingo Nakamoto,Fumio Imazeki,Osamu Yokosuka,L. Bonavina,A. W. Mangel.Factors Associated with Inadequate Tissue Yield in EUS-FNA for Gastric SMT[J].ISRN Gastroenterology.2011
  • 9Peter Hohenberger MD, PhD,Burton Eisenberg MD.Role of Surgery Combined with Kinase Inhibition in the Management of Gastrointestinal Stromal Tumor (GIST)[J].Annals of Surgical Oncology.2010(10)
  • 10H. Scherübl,G. Cadiot,R. Jensen,T. R?sch,U. St?lzel,G. Kl?ppel.Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?[J].Endoscopy.2010(08)

共引文献41

同被引文献123

引证文献25

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部